Endocrinology

Top Story

Long-term GH increases height, not growth potential in juvenile arthritis

November 22, 2017

Researchers in France reported that although long-term treatment with growth hormone improved growth in patients with juvenile idiopathic arthritis, therapy did not fully restore patients’ genetic growth potential.

In the Journals Plus

Short-term sitagliptin therapy preserves beta-cell function in women with PCOS, obesity

November 22, 2017
Among women with polycystic ovary syndrome and obesity participating in a lifestyle intervention, those who were assigned the DPP-IV inhibitor sitagliptin were less…
In the Journals Plus

Joint endocrinologist-nephrologist clinic reduced diabetic kidney disease progression

November 22, 2017
Patients with type 2 diabetes and stage 3 or 4 chronic kidney disease who attended a joint endocrinologist-nephrologist diabetic kidney disease clinic were less likely…
In the Journals PlusPerspective

Despite declines in sugar-sweetened beverage intake, consumption stable among Hispanics

November 22, 2017
Sugar-sweetened beverage intake in the United States declined between 2003 and 2014 in both children and adults, but consumption rates remained steady among…

BLOG: November, again!

November 21, 2017
On Nov. 21, 2016, we launched this blog on Healio.com/Endocrinology. We mutually agreed to call the blog, “From the Doctor’s Bag.” On the occasion of…
More Headlines »
ABIM MOC CME

Ace the Case: A 39-Year-Old Man with Progressive Weight Gain

No commercial support for this activity.

This “Ace the Case” activity will use a case study to discuss obesity management in a patient with progressive weight…
More »
Video
Meeting News

VIDEO: Novel protein plus cold exposure promising for preventing obesity

October 31, 2017
More »
Resource Centers
ObesityWeek

ObesityWeek

CDR CME CNE CPE

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement